Evidence map›Paper›PMID 21285947›Full record

ArticleThe EMBO journal2011

miRNAs control insulin content in pancreatic β-cells via downregulation of transcriptional repressors.

Tal Melkman-Zehavi, Roni Oren, Sharon Kredo-Russo, Tirosh Shapira, Amitai D Mandelbaum, Natalia Rivkin, Tomer Nir, Kim A Lennox, Mark A Behlke, Yuval Dor and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 156 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
156citing papers in PubMed, 2 pooled it
23.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

156 citing papers in PubMed, 2 syntheses or guidelines pooled it, 281 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Liver kinase B1 (LKB1) regulates the epigenetic landscape of mouse pancreatic beta cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Mechanism and recent updates on insulin-related disorders.World journal of clinical cases · 2023
    Review
  16. Article
  17. Article
  18. Review
  19. Human pancreatic islet microRNAs implicated in diabetes and related traits by large-scale genetic analysis.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  20. Article

96 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Tal Melkman-ZehaviDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Roni Oren
Sharon Kredo-Russo
Tirosh Shapira
Amitai D Mandelbaum
Natalia Rivkin
Tomer Nir
Kim A Lennox
Mark A Behlke
Yuval Dor
Eran Hornstein
Weizmann Institute of Science · ILConcern Foundation · USIntegrated DNA Technologies (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) were shown to be important for pancreas development, yet their roles in differentiated β-cells remain unclear. Here, we show that miRNA inactivation in β-cells of adult mice results in a striking diabetic phenotype. While islet architecture is intact and differentiation markers are maintained, Dicer1-deficient β-cells show a dramatic decrease in insulin content and insulin mRNA. As a consequence of the change in insulin content, the animals become diabetic. We provide evidence for involvement of a set of miRNAs in regulating insulin synthesis. The specific knockdown of miR-24, miR-26, miR-182 or miR-148 in cultured β-cells or in isolated primary islets downregulates insulin promoter activity and insulin mRNA levels. Further, miRNA-dependent regulation of insulin expression is associated with upregulation of transcriptional repressors, including Bhlhe22 and Sox6. Thus, miRNAs in the adult pancreas act in a new network that reinforces insulin expression by reducing the expression of insulin transcriptional repressors.

Indexed as

Transcription, GeneticAnimalsBlotting, WesternCell DifferentiationCells, CulturedDEAD-box RNA HelicasesDown-RegulationEndoribonucleasesGlucose IntoleranceHumansImmunoenzyme TechniquesInsulinInsulin-Secreting CellsIntegrasesLuciferasesMiceCre recombinaseDEAD-box RNA HelicasesDicer1 protein, mouseEndoribonucleasesInsulinIntegrasesLuciferasesMicroRNAsRepressor ProteinsRibonuclease IIIRNA, Messenger

Identifiers

PMID21285947
PMCPMC3049206
OpenAlexW2101072639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.